Global HPAPIs and Cytotoxic Drugs Manufacturing Market Analysis Report 2022-2030: Drug Origin, Manufacturing Location, Drug Type, Type of Pharmacological Molecule, Application – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “HPAPIs and Cytotoxic Drugs Manufacturing Market, by Drug Origin, by Manufacturing Location, by Drug Type, by Type of Pharmacological Molecule, by Application, and by Region – Size, Share, Outlook, and Opportunity Analysis, 2022 – 2030” report has been added to ResearchAndMarkets.com’s offering. Highly potent active pharmaceutical ingredients (HPAPIs) have an increasingly significant share … [Read more…]

SIIA Names athenahealth Marketing Team of the Year

Prestigious industry accolade recognizes athenahealth’s refreshed branding effort to elevate its brand and highlight the company’s vision, culture, and commitment to innovation WATERTOWN, Mass.–(BUSINESS WIRE)–athenahealth, Inc., a leading provider of network-enabled software and services for medical groups and health systems nationwide, today announced the Software & Information Industry Association (SIIA) has named it the Marketing … [Read more…]

Accresa Releases Subscription Care Benchmark Report

Data from the Accresa report showcase growing demand for subscription care benefits. DALLAS–(BUSINESS WIRE)–Accresa, a technology provider focused on healthcare payments solutions for employers and provider networks, has released a comprehensive benchmark report on the demand for subscription care amongst employers and employees covered under an employer-sponsored health plan. The report, compiled based on the … [Read more…]

Claims Development Management Earns Fourth NCQA UM Accreditation

MIAMI, Fla.–(BUSINESS WIRE)–Claims Development Management (CDM), a healthcare utilization management organization, established in 2013 and accredited in 2015 to deliver oversight to its clients under the National Committee for Quality Assurance (NCQA) https://www.ncqa.org guidelines, has earned its fourth Accreditation this May 3, 2022. This Recognition exemplifies CDM’s commitment to compliance and excellence in promoting high … [Read more…]

Deepcell Names Life Sciences Operations Leader Kevin Farrell as SVP and Head of Operations

MENLO PARK, Calif.–(BUSINESS WIRE)–Deepcell, a life science company pioneering AI-powered cell classification and isolation for cell biology and translational research, today announced the appointment of Kevin Farrell as SVP, Operations. Kevin brings to Deepcell over 20 years of operations experience in leadership roles at life science companies, including Berkeley Lights and Standard Biotools (previously known … [Read more…]

U.S. Long Term Care Market Trends/Analysis Report 2022-2030: Focus on Skilled Nursing Facility, Home Healthcare, Assisted Living Facilities, Hospice & Palliative Care – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “U.S. Long Term Care Market Size, Share & Trends Analysis Report by Service (Skilled Nursing Facility, Home Healthcare, Assisted Living Facilities, Hospice & Palliative Care and Others), and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. long term care market size is expected to reach USD 779.4 billion by … [Read more…]

Vascular Quality Initiative (SVS VQI) Announces the Expansion of Medicare Coverage to Standard Surgical Risk Patients within their TCAR Surveillance Project

CHICAGO–(BUSINESS WIRE)–The Society for Vascular Surgery® Vascular Quality Initiative® (SVS VQI), a nonprofit organization dedicated to improving the quality of vascular care within hospitals and outpatient facilities, announces that the Centers for Medicare and Medicaid Services (CMS) has expanded coverage for Transcarotid Artery Revascularization (TCAR) to include standard surgical risk patients within the VQI TCAR … [Read more…]

Propanc Biopharma’s PRP to Target 80 – 90% of Cancer Cases

PRP Prevents Recurrence and Metastasis by Targeting and Eradicating Cancer Stem Cells MELBOURNE, Australia–(BUSINESS WIRE)–Propanc Biopharma, Inc. (OTCQB: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today announced that the Company’s lead product candidate, PRP, targets solid tumors, which accounts for 80 – … [Read more…]

Antidote Technologies and the National Minority Health Association Collaborate to Increase Diversity in Clinical Trial Recruitment

The relationship will bolster Antidote’s DE&I initiatives in patient recruitment and support NMHA’s health equity mission to close the healthcare gap in minority and underserved communities NEW YORK–(BUSINESS WIRE)–Antidote Technologies (Antidote), a patient-centric digital engagement company focused on connecting patients with clinical research, today announced a collaboration with the National Minority Health Association (NMHA), a … [Read more…]

Cohen Children’s Medical Center Ranks No. 1 on Long Island

New York State’s largest pediatric trauma center given high marks by US News & World Report NEW HYDE PARK, N.Y.–(BUSINESS WIRE)–Cohen Children’s Medical Center has been rated the No. 1 children’s hospital on Long Island – and recognized as second in New York State, sixth in the mid-Atlantic region – while earning top 40 national … [Read more…]